Trials / Completed
CompletedNCT04506216
Eating Disorders in Type 1 Insulin-dependent Diabetes Patients
Prevalence of Eating Disorders in Adult Patients With Type I Diabetes and Insulin Pump Treatment
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- Icadom · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the prevalence of eating disorders in type 1 insulin-dependent diabetes patients
Detailed description
The risk of developing an eating disorder is increased in type 1 diabetes patients and associated with a poor prognosis in terms of glycemic control, metabolic complications, degenerative complications, and mortality. Therefore the terminology diaboulimia has emerged to characterize an eating disorder specific to type 1 insulin-dependent diabetes patients, with insulin under dosage with a view of losing or controlling weight and that can contribute to a deterioration of the body composition. The purpose of this study is to determine the prevalence of eating disorders in an adult cohort with type 1 insulin-dependent diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | cohort | During a regular follow-up visit, the following data will be collected: * questionnaires on lifestyle, eating custom (SCOFF-F, 5th question of the m-SCOFF) and physical activity (IPAQ) * bio-electric impedance analysis * insulin pump and sensor data collection |
Timeline
- Start date
- 2020-09-01
- Primary completion
- 2021-12-23
- Completion
- 2021-12-23
- First posted
- 2020-08-10
- Last updated
- 2022-04-08
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04506216. Inclusion in this directory is not an endorsement.